XTL BIOPHARMACEUTICALS LTD. Adjustments For Reconcile Profit Loss
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Adjustments For Reconcile Profit Loss of $189.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForReconcileProfitLoss · last filed 2025-04-30
| Period end | Adjustments For Reconcile Profit Loss 6 month | Adjustments For Reconcile Profit Loss 12 month |
|---|---|---|
| 2024-12-31 | $189.00K 20-F · filed 2025-04-30 | |
| 2023-12-31 | $64.00K 20-F · filed 2025-04-30 | |
| 2022-12-31 | -$19.00K 20-F · filed 2025-04-30 | |
| 2022-06-30 | -$169.00K 6-K · filed 2022-08-24 | |
| 2021-12-31 | -$54.00K 20-F · filed 2023-03-22 | |
| 2021-06-30 | -$191.00K 6-K · filed 2022-08-24 | |
| 2020-12-31 | $45.00K 20-F · filed 2023-03-22 | |
| 2020-06-30 | $17.00K 6-K · filed 2021-08-24 | |
| 2019-12-31 | -$50.00K 20-F · filed 2022-03-30 | |
| 2018-12-31 | -$8.00K 20-F/A · filed 2021-05-19 | |
| 2017-12-31 | $52.00K 20-F · filed 2020-03-12 | |
| 2016-12-31 | -$220.00K 20-F · filed 2019-03-11 | |
| 2015-12-31 | -$16.00K 20-F · filed 2018-03-15 |